India is among the top six global pharmaceutical producers in the world. Indian vaccines are exported to 150 countries. India produces 40-70 per cent of the WHO demand for DPT & BCG and 90 per cent of measles vaccine. Approximately 70 per cent of the patients in developing countries receive Indian medicines through NGOs like The Clinton Foundation, Bill & Melinda Gates Foundation, Doctors without Borders, the UNCTAD etc.
This PPT contains complete analysis of Pharmaceutical Industry including worldwide and nationwide picture, leading organizations, SWOT analysis, Government policies and regulations, challenges and solutions.
Pharmaceuticals Industry Analysis with analysis of Top notch Companies in pharmaceuticals viz. Sun pharma, Lupin, Dr. Reddy's Laboratory, Cipla, Aurobindo Pharma to identify opportunity to invest in equity share of these companies.
India is among the top six global pharmaceutical producers in the world. Indian vaccines are exported to 150 countries. India produces 40-70 per cent of the WHO demand for DPT & BCG and 90 per cent of measles vaccine. Approximately 70 per cent of the patients in developing countries receive Indian medicines through NGOs like The Clinton Foundation, Bill & Melinda Gates Foundation, Doctors without Borders, the UNCTAD etc.
This PPT contains complete analysis of Pharmaceutical Industry including worldwide and nationwide picture, leading organizations, SWOT analysis, Government policies and regulations, challenges and solutions.
Pharmaceuticals Industry Analysis with analysis of Top notch Companies in pharmaceuticals viz. Sun pharma, Lupin, Dr. Reddy's Laboratory, Cipla, Aurobindo Pharma to identify opportunity to invest in equity share of these companies.
Industry analysis conducted at vodafoneProjects Kart
This is detailed management project conducted at Vodafone to analyse the industrial trends in telecom. Visit us for more information on http://www.projectskart.com/p/contact-us.html
Aashirvaad success story as a backward integration from tobacco to FMCG company.
includes every aspect of Marketing and brand building strategy of ITC limited.
Includes ITC history of famous aashirvaad atta's success story of being the No 1 packaged atta in the industry.
this project consists of the following main elements which are as follows:
ITC's Brand elements, marketing programmes, brand building strategies, manufacturing, and competitors analysis
GlaxoSmithKline GSK CH - A report on Business Strategy and Growth Avenues in ...Maneesh Garg
A summer internship report on GlaxoSmithKline Consumer Healthcare (GSKCH) Himachal Pradesh. Report comprises the sales structure, business and supply chain model of GSK Consumer Healthcare in Himachal Pradesh. It also includes the comparative analysis of GSK supply chain and sales structure with competitor FMCG companies like HUL, P&G, Nestle and Colgate etc, Himachal Pradesh geographical audit, revenue model, remunerations of sales team, incentives and much more...
To get a copy of this presentation, share your views about the presentation with your email id in Comments section... I keep on updating my presentations and documents. To ensure that you don't miss any update or new upload don't forget to press the "FOLLOW" and "LIKE" button
Vibrant Gujarat Summit Profile on Healthcare Sector investmentVibrant Gujarat
To be the network of finest public healthcare institutions in the state of Gujarat, providing quality medical care services with the state of the art technology with easy accessibility, affordability & equity to the people of Gujarat & beyond.
Medical services are meant for curative care via diagnosis and treatment. Medical Relief services mainly are centred in the urban areas of the state and are delivered through the following hospitals, which are the leading hospitals at the district and State Infrastructure hospitals, the sub‐district level for all the districts.
Industry analysis conducted at vodafoneProjects Kart
This is detailed management project conducted at Vodafone to analyse the industrial trends in telecom. Visit us for more information on http://www.projectskart.com/p/contact-us.html
Aashirvaad success story as a backward integration from tobacco to FMCG company.
includes every aspect of Marketing and brand building strategy of ITC limited.
Includes ITC history of famous aashirvaad atta's success story of being the No 1 packaged atta in the industry.
this project consists of the following main elements which are as follows:
ITC's Brand elements, marketing programmes, brand building strategies, manufacturing, and competitors analysis
GlaxoSmithKline GSK CH - A report on Business Strategy and Growth Avenues in ...Maneesh Garg
A summer internship report on GlaxoSmithKline Consumer Healthcare (GSKCH) Himachal Pradesh. Report comprises the sales structure, business and supply chain model of GSK Consumer Healthcare in Himachal Pradesh. It also includes the comparative analysis of GSK supply chain and sales structure with competitor FMCG companies like HUL, P&G, Nestle and Colgate etc, Himachal Pradesh geographical audit, revenue model, remunerations of sales team, incentives and much more...
To get a copy of this presentation, share your views about the presentation with your email id in Comments section... I keep on updating my presentations and documents. To ensure that you don't miss any update or new upload don't forget to press the "FOLLOW" and "LIKE" button
Vibrant Gujarat Summit Profile on Healthcare Sector investmentVibrant Gujarat
To be the network of finest public healthcare institutions in the state of Gujarat, providing quality medical care services with the state of the art technology with easy accessibility, affordability & equity to the people of Gujarat & beyond.
Medical services are meant for curative care via diagnosis and treatment. Medical Relief services mainly are centred in the urban areas of the state and are delivered through the following hospitals, which are the leading hospitals at the district and State Infrastructure hospitals, the sub‐district level for all the districts.
Detailing the overall profile of the Healthcare sector in India and Gujarat, this presentation makes a point for the immense business & investment opportunities present in the sector owing to government initiatives & schemes to achieve accessible, affordable & quality healthcare for all.
The Indian healthcare industry has progressed at an impressive pace over the past few years. The private sector has emerged as a vibrant force in the industry, accounting for almost 74 per cent of the country’s total healthcare expenditure.
The Indian healthcare revenues stood at US$ 68.4 billion in 2011 and is expected to reach US$ 158.2 billion by 2017. Of the total healthcare revenues in the country, hospitals account for 71 per cent, pharmaceuticals for 13 per cent and medical equipment and supplies for 9 per cent.
India offers both a huge patient pool, favourable regulatory environment and cost advantage for conducting clinical trials. The low cost of medical services has resulted in a rise in the country’s medical tourism, attracting patients from across the world.
The Government of India has created the National Health Mission (NHM) for providing effective healthcare to both urban and rural population.
This is a report about Indian Health care industry and How different sectors like Hospitals, Pharmacy and Diagnostics industry are growing. What are the new government policies that are implemented for Health care sector in India.
An expansive set of schemes and initiatives like SMART Cities, AMRUT Mission, Swachh Bharat, etc. by the government are aimed at urban development. This move of the government presents many business & investment opportunities in this sector to transform the urban regions of India. Gujarat, already a fast developing state of the nation has various initiatives to enable it to achieve world class infrastructure & living standards.
Tourism industry the Gujarat Experience SectorVibrant Gujarat
This presentation details the overview of the tourism sector of India & Gujarat. It highlights the business opportunities present in the sector owing to robust growth in tourist inflow in the state. Various government incentives & policies are also listed to promote investment & cinematic tourism
This presentation highlights the strength of the textile sector in India as well as Gujarat. Detailing the strong manufacturing capacity as well as the easy availability of raw materials, the presentation makes a strong case for the immense business & investment opportunities present in the sector.
Highlighting the government’s focus on Skill Development to achieve economic & social development through the country’s huge active population (between 15-45 years), the presentation details the changing scenario of the skill development sector in India and the state of Gujarat.
The mammoth energy requirements of India coupled with the strong push being provided by the government to renewable sources of energy makes this sector a lucrative business prospect. This presentation details the overview of the renewable energy sector in India as well as Gujarat and highlights the business opportunities available within the sector.
This presentation details the overall scenario of the pharmaceutical sector in India as well as the state of Gujarat. The presentation highlights the investment & business opportunities present in the sector owing to the robust growth of the sector in India as well as Gujarat. Various government assistance schemes & incentives further augment the business potential of the sector.
This presentation gives an overview of the Micro, Small & Medium Enterprise sector in the state of Gujarat as well as India. While detailing the various incentives & schemes given by the government to different MSMEs, the presentation makes a strong case for growth of MSMEs in the state through the assistance provided by the government under Industrial policy 2015
Mega projects avenues for-investment in Gujarat SectorVibrant Gujarat
Detailing the overview of the mega projects sector in Gujarat, this presentation highlights the robust infrastructure & infrastructure capacities in various projects like Smart Cities, Industrial Corridor, SEZs etc. in Gujarat. It also specifies various avenues of investment present in the state for this sector.
Information Technology and Information Technology Enabled Services SectorVibrant Gujarat
Highlighting the value proposition of the ever growing IT-ITes Sector in India, this presentation gives an overall idea about the future of the sector in India as well as Gujarat. It mentions the various initiatives, incentives and schemes launched by the Government of India and the Government of Gujarat to promote business and investment in the sector.
This presentation details the overall scenario for the Gems & Jewellery Sector in India as well as Gujarat. It highlights the business & investment opportunities present in the sector and also the government initiatives and interventions.
This presentation details the overall profile of the environment sector. It highlights the overview of the sector and also lays down guidelines for environment conservation. Lastly, it presents the current business and growth opportunities in the sector for sustainable development.
Detailing the profile of the engineering sector, this presentation highlights the size and scale of the industry in the nation as well as the future path for development of the industry. It lays down key FDI polices as well as the current business opportunities.
Electronic Sytem Sesign and Manufacturing SectorVibrant Gujarat
This presentation profiles the Electronic System Design and Manufacturing (ESDM) sector presenting the key facts & figures, policy interventions, electronics policy of Gujarat state and current business and growth opportunities.
Presenting the overall profile of the Chemical and petrochemical sector, this presentation highlights the current scenario of the industry, policy intervention, advantages of the industry and current business opportunities
This presentation on the biotechnology sector details the initiatives, infrastructure and policies developed by the government to promote growth of the sector and also highlight the current business opportunities present in this sector.
This presentation imparts a complete overview of Gujarat’s Forest Sector including information about the government initiatives, projects and schemes for collaboration opportunities as well as sustainable development by preserving the biodiversity & forest ecosystem
This presentation highlights the overview and subsidiaries of the agro and food processing sector in India & Gujarat. It details the major initiatives taken up by the government in terms of policies as well as infrastructure to promote industries and investments in the sector.
This presentation details the overview of the aerospace & defense sector. It highlights the current scenario of the sector in India as well Gujarat and also features details about government policies and Make in India initiative to develop industries & promote investment in the sector.
Vibrant Gujarat 2015 Interaction Meeting in IndoreVibrant Gujarat
Government of Gujarat organized a Roadshow in Indore to showcase the forthcoming Vibrant Gujarat 2015 Summit being organized on 11–13 January, 2015 in Mahatma Mandir, the state-of-the-art convention center in the state capital Gandhinagar. The seventh edition of Vibrant of Vibrant Gujarat Summit will be led by Hon’ble Chief Minister of Gujarat Smt. Anandiben Patel.
Shri Babubhai Bokhiriya, Minister for Fisheries, Water Resources, Water Supply, Agriculture, and Cooperation spearheaded the Roadshow at Hotel Radisson Blu, which was attended by over 180 top industrialists and corporate leaders from the state of Madhya Pradesh and Chhattisgarh. Participants at the seminar represented a wide range of sectors such as Manufacturing, Auto and Auto ancillaries, Agri Business & Food processing, Textiles, Pharmaceuticals, Cement, Power & Renewable Energy, Mines & Minerals, Forest, IT/ITES and Infrastructure.
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Explore our infographic on 'Essential Metrics for Palliative Care Management' which highlights key performance indicators crucial for enhancing the quality and efficiency of palliative care services.
This visual guide breaks down important metrics across four categories: Patient-Centered Metrics, Care Efficiency Metrics, Quality of Life Metrics, and Staff Metrics. Each section is designed to help healthcare professionals monitor and improve care delivery for patients facing serious illnesses. Understand how to implement these metrics in your palliative care practices for better outcomes and higher satisfaction levels.
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
The Importance of Community Nursing Care.pdfAD Healthcare
NDIS and Community 24/7 Nursing Care is a specific type of support that may be provided under the NDIS for individuals with complex medical needs who require ongoing nursing care in a community setting, such as their home or a supported accommodation facility.
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
3. Overview: Factors for growth in healthcare
Increasing
population
Total global healthcare expenditure represent
around 10% of world GDP. Indian health sector is
expected to create 40 million new jobs by 2020.
Increasing
disposable
income
Focus on
PPP India’s medical device market is currently the 4th
largest in Asia with 700 medical device makers,
Factors for
projected growth
in healthcare
Growing
health
issues
Govt.
initiatives
and ranks among the top 20 in the world
Cheaper
cost of
treatment
Improving
health
insurance
India has got many enabling factors to support its
growth in health sector. It is equipped to deliver on
global demand.
418 State‐of‐the‐art Maternal and Child Health
Wings have been sanctioned in 2012‐13 across 11
States
Thrust on
medical
tourism
penetration
Sources: www.pib.nic.in
4. Strong Policy Support
Encouraging
the private
The benefit of section 10 (23 G) of the IT Act has been extended to
financial institutions that provide long‐term capital to hospitals with 100
beds or more
sector Government is encouraging thhe PPP moddell to improve availlabbillity off
healthcare services and provide healthcare financing
Encouraging
The benefit of section 80‐IB has been extended to new hospitals with 100
investments
in rural areas
beds or more that are set up in rural areas; such hospitals are entitled to
100% deduction on profits for 5 years
C d lif i i h b d d 5% f 25%
Tax incentives
Customs duty on life‐saving equipment has been reduced to from and exempted from countervailing duty
Import duty on medical equipment has been reduced to 7.5%
Incentives in
the medical
travel
Incentives and tax holidays are being offered to hospitals and dispensaries
providing health travel facilities
industry
Sources: www.ibef.org
5. FDI Inflows & Health Insurance
100% Foreign Direct Investment (FDI) is permitted
for all health‐related services under the automatic
route. Demand growth, cost advantages and policy
support have been instrumental in attracting FDI
The health insurance premium has registered a
CAGR of 32 % for the past 8 financial years.
Indian health insurance industry with gross
premiums has increased by 16 % from USD 2.1
Billi i 2011 12 t USD 2 4 Billi i 2012 13
FDI inflows (Apr 2000 –Mar 2013) into the
healthcare sector
Billion in 2011‐to 2.4 Billion in 2012‐0.2 Cumulative
1.8
2.1
2.4
1 FDI flows
1.9 0.5
(USD billion)
1
1.3
10
5
Share of
l FY09 FY10 FY11 FY12 FY13
Drug & Pharmaceuticals
diagnostic centres
total FDI
inflows (%)
Sources: Department of Industrial Policy & Promotion (DIPP)
Health Insurance Premium (USD Billion)
Hospital & Medical & Surgical Appliances
6. Opportunities in Healthcare
Additional 1.8 million beds needed for India to achieve the target of 2 beds per
1,000 people by 2025
Additional 1.54 million doctors required to meet the growing demand for
healthcare
Healthcare
Infrastructure
Investment of USD 86 billion required to achieve these targets
Less than 15% of the Indian population is covered through health insurance
l h
p p g
The total market size of the insurance sector in India was USD 66.4 billion in FY 13.
It is projected to touch USD 350–400 billion by 2020.
Health
Insurance
Indian medical tourism industry is expected to register a CAGR of more than 20%
during 20132015
nearly (1/10) th of the cost in developed countries
Medical
Tourism
Cost of surgery in India is Contract research is a fast growing segment in the Indian healthcare industry
Cost of developing new drug is as low as 60% of the testing cost in the USA
Research &
Development
About 60% of global clinical trials is outsourced to developing countries
Sources: From research report “Booming Medical Tourism in India”, www.ibef.org
8. Gujarat Public Health Infrastructure
Gujarat state is in the forefront of establishing and maintaining good health infrastructure
State Medical Infrastructure
Super
Specialty
Facility
District
Hospitals
18
Sub‐District
Hospitals
30
Mobile
Health Units
129
Community
Health
Centers
300
Primary
Health
Centre
1208
Sub –
Centre
7744
Medical
Colleges
19
3 AYUSH Facilities:
Ayurved Hospitals : 4400 ;; AAyyuu DDiissppeennssaarriieess :: 552233;; HHoommeeooppaatthhyy HHoossppiittaallss :: 44;; HHoommeeoo DDiissppeennssaarriieess :: 221166
GrantinAid
(GAI) Hospitals: 119
9. Medical and Para Medical Colleges
Total of 19 Institutions with 2930 Seats
■ 6 Government Colleges (1080 Seats)
■ 5 Gujarat Medical Education & Research
Total of 13 Institutions with 1240
Seats
■ 2 Government Colleges (200 Seats)
Society (GMERS) Medical Colleges (750)
■ 4 Private Colleges (500 Seats)
■ 3 Municipal Corporation College (450
seats)
■ 1 SGDHER (100 seats)
■ 1 Municipal Corporation College
(100 Seats)
) ■ 8 Private Colleges (740 Seats)
■ 1 Deemed University (150 Seats) ■ 1 Deemed University (100 Seats)
Total of 41 Institutions with 1855
Seats
Total of 34 Institutions with 1730
Seats
■ 5 Government Colleges (360 Seats) ■ 8 Government Colleges (390 Seats)
■ 33 Private Colleges (1465 Seats)
■ 1 Municipal Corporation College (50
Seats)
■ 26 Private Colleges (1270 Seats)
■ 2 Deemed Universityy ((50 Seats))
As on 10th August, 2014
10. Para Medical Colleges & Indian System
of Medicine & Homeopathy
Total of 17 Institutions with 1625 Seats
4 GrantinAid
Colleges (400 Seats)
4 Self Financed Institutions
with a total of 125 Seats
13 Self Financed Colleges (1225
Seats)
Para Medical
Colleges &
ISM&H
1 G C ll i h l f
Total of 10 Institutions with 465 Seats
4 Government Colleges (180 Seats)
2 GrantinAid
Colleges ( 85 Seats)
Government College with a total of
10 Seats
g )
3 Self Financed Colleges (150
Seats)
1 University Ayurveda College (50)
As on 10th August, 2014
12. Fostering Partnerships: Innovative PPP model
Chiranjeevi Yojna
Joint collaboration (PPP) between Government of Gujarat and Private
Gynecologists/Trust Hospitals
Service Coverage through outsourcingfor
normal delivery, Emergency
Obstetric Care and Neonatal Care
Below Poverty line family and nonincome
tax paying Tribals
Voucher System (Cash Less)
A package of INR 3.80 lacs (USD 6333) is given for 100 deliveries
Linked with 108 emergency transport
• Provided facilities for proper check up of newborns and infants by
• pediatricians
Main aim of the scheme is to bring down the Infant Mortality Rate
Bal
Sakha
Yojna
(IMR) and the Maternal Mortality Ratio (MMR)
13. Fostering Partnerships
PPeriinattall RRefferrall SServiices 110088: A PPP
Initiative with GVKEMRI
• Existing Fleet of :525 Ambulances
l dd 55
State of the
• Total Emergencies Attended :43,44,255
• Pregnancy Related Cases :14,97,824
• Deliveries in Ambulance & at Scene
Art – PPP
Institutions
:45 45,272
272 Current infrastructure + proposed investment +
• Response time :Urban areas 13.37
minutes & Rural areas 23.42 minutes
KHILKHILAT” D B k S i
p p
technology and management expertise =
enhanced resource utilization and
improved access to healthcare
KHILKHILAT”: Drop Back Services
CM – SETU: Chief Minister Services of Experts at Treatment Unit
• To address shortage of specialists, CM SETU scheme has been
launched byy the state. Expperts from Private institutes like
Gynecologist, Physician, Surgeon, Orthopedician, Pediatrician,
Ophthalmic Surgeon, Anesthetist, ENT Surgeon, Dermatologist,
Psychiatrist, Radiologist, Pathologist are outsourced to provide
services & patients' treatment cost is borne by the state
A Free drop back facility service for
deliveries in Government Health facility
specialist patients government.
14. Mukhyamantri Amrutum (MA)
544 procedures
Cashless
hospitalization
benefit of
INR 200,000 (USD
in the
Private/ Government
Empanelled
Hospital
3333) per BPL
Family (5)
per annum
100% State
funded
Scheme
Provides tertiary
care treatment for
hi di
More than
2.144 Million
BPL f ili
Current Status
of the Scheme
Mukhyamantri
Amrutum
catastrophic diseases
To all BPL families and
all females and
children up to 21
years of families having
35,607 claims
families
enrolled
income less than 1.20
lacs (USD 2000)
Preexisting
diseases are
amounting to
INR 71.08 Crores
(USD 11.84
million) have
occurred till
covered from
day one
63 Super
Specialty
Hospitals
Empanelled
Provision for
transport
allowance August 2014
of
p
Rs.300 per visit
15. School Health Program (SHP) + RBSK
Salient Features & Outcomes
Salient Features
Beneficiaries Bouquet “Newborn
to 18 Years”
Health Screening and Medical
check up based on 4D’s:Defects
at Birth, Diseases, Deficiencies
Covers More than 15.6 Million
children of Gujarat, about 26 %
of total population
All di t i t d C ti
Primary School
Children: 90 26 049
, ,
and Disabilities
SuperSpecialty
treatment for
Heart, Kidney and Cancer
districts and Corporations are Disease including Renal
involved in this program &
Community Awareness and
Participation Activities are
organized
90,26,049
Secondary and Higher
Secondary School Children:
25,56,287
Transplant, Liver transplant,
Cochlear implant and Clubfoot
(201314)
g
Health and LifeSkills
education
Health & Referral Card with
tracking for SuperSpecialty
New born to 6 years Angan
Wadi Children: 39,55,276
Non School going
SHP to School Health Week:
A Flagship Programme
Free Spectacles Distribution
Referrals
children:65,295
Madressa: 16,318
Children/ Juvenile
Home etc : 3,050
16. Sickle Cell Anemia (SCA) Control Program
20% of Sickle disease children
die by the age of two years
>50% of the world Sickle
gene carriers in India
30% of sickle disease children among the tribal
community die before they reach adulthood
Components of the Program
Crisis Management
• Supportive & Referral Treatment
• Regular follow up and counseling
• Prevention through:
Pneumococcal vaccination
Marriage Counseling
Crisis
Management Prevention
Genetic Counseling
Building Community
Awareness
Early
Diagnosis Regular
Early diagnosis through
New Born Screening
Prenatal Diagnosis
Antenatal Screening
Regular Training
• Doctors and Paramedical staff g
Training
Adolescent Screening
Mass Screening on
mission mode
• Health care providers & ASHA
• VHSNC members & Teachers
Tribal Population is
the target group
SCA seen in all 14 tribal districts – all covered
under Sickle Cell Anemia Control Program
But any person suffering from Sickle
Cell Anemia is the main beneficiary
17. Sickle Cell Anemia Control Program
Year Wise Screening of Tribal Population
More than 6.3 Million tribals screened of which 5,80,580 Sickle Cell trait and 29584
7
2.5
sickle cell disease detected
Q t J i
2.07
1.94
2
1 5
Quantum Jump since
201213
after outsourcing
ened
4
26
.32
.33
0.34
0.4
1.5
1
0 5
ulation Scree
0.14
0.2
0
0
0
0
0.5
0
607
708
809
910
011
112
213
314
Popu
2006
2007
2008
2009
2010
2011
2012
2013
Population screened (In Million)
Expon. (Population screened (In Million))
Recipient of the Prime Minister Award for Excellence in Public Administration
18. National Public Health Program
National Vector Borne Disease Control Programme (NVBDCP): During 2012, 0.36 Million Long Lasting
Insecticide treated Nets (LLINS) were distributed in high risk areas. 0.9 Million beneficiaries were
pprotected
Revised National T.B. Control Programme (RNTCP): Total 0.16 Million lives
saved since the inception of RNTCP.
National Leprosy Eradication Programme: 4597 leprosy
patients are under treatment in the State.
National Blindness Control Programme: IInn 22001122‐‐1133 uupp ttoo OOccttoobbeerr‐‐ 1122,
state has performed 0.4 Million cataract operations. Out of which,
99.41% were operated with IOL.
Sources: SocioEconomic
Review 201213
19. Gujarat Medical Service Corporation Limited
(GMSCL)
• Rational Use of Drugs and Standard Treatment Guidelines
• Procurement of quality Branded Generic Drugs/ Promotion of
GGeneriic DDrugs
• Procurement of Medical Instruments and Maintenance
• Diaggnostics Centers and Services
• Strengthen Supply Chain Management to ensure smooth and
timely supply of Drugs & Instruments to Public Health
Institutes
21. Healthcare Sector: Awards and Accolades
Prime Minister Award for Excellence in Public
Administration for the year 2009‐10 to
Sickle Cell Anemia Control Program, Gujarat
Award for best
practices in
Healthcare delivery in
2011 in Ahmedabad
Chiranjeevi Yojna:
Asia Innovation Award 2006 (Singapore)
Prime Minister’s Award, Administrative Excellence in 2009
Award at IndiZen 2014
for operational
excellence in Pune
FICCI Healthcare
excellence Award for
CCHHCC BBarddollii 22001133
22. Gujarat – The Pharmaceutical Hub
109 years of
excellence
Only manufacturer of
Doxorubicin HCL
Liposome injection in the
World at present
70% of India’s 50% of India’s
80% of world’s Isoniazid
(used for treatment of
tuberculosis) is produced
in Gujarat
Only manufacturer of
Vitamin C and Dapsone
in India
India s
cardiac stents
manufactured is
from Gujarat
India s
intraocular lenses
manufactured is from
Gujarat
~40% of India’s machinery
for pharma sector
manufactured is from
Gujarat
58% India’s orthopedic
implants manufactured
is from Gujarat
j
40% of 3324 manufacturing 33% of India’s pharma Produces 35% of
CRAMS
Companies
India’s Diagnostic Re‐agent
sector turnover; 28% of
India’s pharma export
licenses; Home to ~40%
of CRO in the country
Gujarat, an established manufacturing base for bulk drugs and formulations, is poised to capture global
opportunities to become a Global Pharmaceuticals Hub
i i b Gl b l Ph i l H b
23. Gujarat – The Pharmaceutical Hub
Manufacturing
Units in
Gujarat (till
March, 2014)
Allopathic Ayurvedic Cosmetics Homeopathic Total
2313 625 394 8 3339
Gujarat's Pharma
Exports
exports
2820
3000
2500
Pharma Exports from Gujarat USD million
40% 60%
ncrease in e
2000
1500
1000
Formulation Bulk Drugs
1584 % in
178
500
0
2004 2013
Gujarat manufactures and exports different dosage forms including generic drugs, intricate vaccines, r‐
DNA products, cytotoxic drugs external preparations, sex hormone drugs, small and large volume
parenterall, AAPPIIs, hhii‐techh carddiiac stents bbiio‐phharma prodducts etc
27. Pharmaceutical Sector
Gujarat: Educational Infrastructure
ll f h h d b d
Education / research
institutes
Research and
L M College of Pharmacy, Ahmedabad
Institute of Pharmacy ‐ Nirma University, Ahmedabad
National Institute for Pharmaceutical Education and
Research (NIPER) ‐ Ahmedabad
Faculty of Pharmacy, MS University, Vadodara
development
Manufacturing
Zydus Cadila Healthcare Ltd.
Claris Life sciences Ltd.
Cadila Pharmaceuticals Ltd.
Intas Pharmaceutical Ltd.
Sun Pharma
Torrent Pharmaceuticals Ltd.
Dishman Pharmaceuticals
Abott Laboratories
Wyeth
Jubilant Organosys
Marketing and exports
Contract research organizations
Lambda Therapeutics
Quintiles Research (India) Private Limited
Kendle INC Research
Thermofisher Biopharma Services (i) Pvt. Ltd.
SSyynncchhrroonn RReesseeaarrcchh SSeerrvviicceess PPrriivvaattee LLiimmiitteedd
B A Research India Limited
Provisional Intake Capacity of Pharmacy Colleges
in Gujarat (201314)
Govt./GIA or Self
Financed
No. of
Colleges
Intake
Capacity
Govt./GIA 4 235
Self Financed 78 4890
Total 82 5125
Source: The Admission Committee for Professional Courses
28. Pharmaceutical Sector
Gujarat: Investment Opportunities
• Contract manufacturing
organisation ( CMO)
• Manufacturing of ayurvedic
g ) preparations
• Manufacturing of new
dosage forms like patches
• Manufacturing of active
pharmaceutical ingredient
Manufacturing
• Manufacturing of
recombinant DNA based
products
• Manufacturing of
• Manufacturing of allopathic
products
• Manufacturing of cosmetic
products
M f i f
intermediates and fine
chemicals
• Manufacturing of
medical devices
• Manufacturing of
biopharmaceuticals
• Manufacturing of
oncology products
• In Research and Development, opportunities for investment lies in Contract Research Organization
((CRO)),, Clinical research,, Genetic enggineeringg and Settingg of R&D Centres & CoEs
• There are opportunities for investment in Retail Stores and Pharmacy Chain too.
29. Pharmaceutical Sector
FDCA: Awards and Accolades
Award for Swarnim Swanthah Sukhaya
Project – 2012 in Category “To make more
comppetent and incorrupptive syystem of ppublic
C S I ‐ IT Excellence
Award 2012 (Health –
IInnffrraa && SSoolluuttiioonnss))
National eGovernance
Gold Award 2013, by
GGoovveerrnnmmeenntt ooff IInnddiiaa
eINDIA
Gold Award in Health Sector,
y Hyderabad, ,
2013
Selected for National Rapid RollOut
Programme in 2013 by DeiTY, Government of
India
30. Medical Tourism in Gujarat
State Medical Tourism policy was
announced in 2006. The following
factors can further boost medical
tourism:
(1/10)th ‐ (1/20)th of
the costs involved for
medical treatment in
USA UK Knowledge
Zero waiting periods
for all patient either
requiring emergency
treatment Assisted healthcare institutions
such as day care centres
Support services such as
or UK. of English is an
additional advantage
or
otherwise
Good roads and nursing associations
Linkages with infrastructure
infrastructure
compared to other
states of India. Well
connected with the
base metros like
Key facilitators for
Advantage Gujarat
facilities for transportation of
patients from airports and
Gujarati doctors railway stations
ld
Delhi and Mumbai
Large percentage of Non
Linkages with organisations/
NGOs, etc., in overseas countries
to acquire knowledge and
participating in world
medical conferences
which helps them to
know latest
developments in the
Resident Gujaratis
(NRG) among Non
Resident Indians (NRI)
q g
leverage opportunities
medical field
31. Investment Opportunities
PPP for
Healthcare
facilities in
Rural Areas of
State
Upgraded IT
Services for
Computer Healthcare
navigated
Setting up of
Diagnostic
services
Tele‐medicine
Integrated
medicity
High – tech Tele
surface
replacement
surgery of the
hip and knee‐joint
Healthcare
Infrastructure
Rehabilitation
Center
g
Super specialty
hospitals
and Tele‐radiology
Establishing projects
chain of
primary public
/ it
g
MRI/ CT scan
facilities
j
Hospital
supplies Reform
Strategy
–
Non‐Emergency
Ambulance
transport
service
Holistic
wellbeing –
yoga,
community
centers
physiotherapy,
acupressure d
Institutional
Management,
Collaboration
with the private
sector (PPP)
Low cost paid
surrogacy
through in vitro
Fertilization
Equipment
Clinical
research and
Hospital trials
management on
rehabilitate Manufacturing
Units
rehabilitate,
operate and
transfer (ROT)
basis
32. Glossary
ASHA – Accredited Social Health Activist
SCA ‐ Sickle Cell Anemia
VHSNC ‐ Village Health, Sanitation and Nutrition
Committee
PPP ‐ Public–Private Partnership
GDP – Gross Domestic Product
FDI – Foreign Direct Investment
IOL – IntraOcular Lens
CHC – Community Health Centres
FICCI Federation of Indian Chambers of Commerce
USD – US Dollar
INR – Indian Rupee
CAGR ‐ Compounded annual growth rate
‐ and Industry
CRAMS – Contract Research and Manufacturing
Services
NGO ‐ Non‐governmental organization
AYUSH – Department of Ayurveda, Yoga and
Naturopathy, Unani, Siddha and Homoeopathy
SGDHER Health
CRO – Contract Research Organization
API ‐ Active Pharmaceutical Ingredients
CoE – Centre of Excellence
‐ Society for Gujarat Dental Health,
Education and Research
GVKEMRI
‐ GVK Emergency Management and
Research Institute
DeiTY ‐ Department of Electronics and Information
Technology
MRI ‐ Magnetic Resonance Imaging
CM SETU ‐ Chief Minister Services of Experts at
Treatment Unit
BPL – Below Poverty Line
CT Scan ‐ Computerized RBSK ‐ Rashtriya Bal Swasthya Karyakram Tomography Scan
Note: 1 USD = 60 INR
33. For Additional Information Connect Us @
Health and Family Welfare Department
Government of Gujarat, INDIA
7th Floor, Block 7,
Sardar Patel Bhavan, Sachivalaya,
Gandhinagar, Gujarat, India ‐ 382010
hhttp:////www.gujhheallthh.gov.in//
Phone: 079‐23251401
E‐mail: cohealth@gujarat.gov.in ; hgvg2015@gmail.com